Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)
NCT03567408
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Coronary Heart Disease
Interventions
PROCEDURE:
Selective PCI
DRUG:
Bivalirudin
Sponsor
Qian Gong